The first group comprised gastric cancers that had low DOK6 expression and FRA18C copy number deletion (n = 24); the second group comprised all other gastric cancers in the same data set without FRA18C deletion and DOK6 expression above the lowest quartile (n = 229). This evidence concerns the gene DOK6 and gastric cancer.